Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 78.97 lakh contracts with a turnover of Rs. 6,92,766.23 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 3.0

Overall volumes in futures & options currently stand at 78.97 lakh contracts with a turnover of Rs. 6,92,766.23 crore.

Index trend and stocks in action October 16, 2018
Index trend and stocks in action October 16, 2018

Index trend and stocks in action October 16, 2018

Karan Dsij Article rating: 5.0

We expect the index to continue with its pullback up to the level of 10,560 as it is the 38.2 per cent retracement level of the recent down-move. Stocks in news: NTPC, Globus Spirits, IFCI, TV Today Network and OCL India.

Markets may begin on a tepid note despite positive cues from Asian peers
Markets may begin on a tepid note despite positive cues from Asian peers

Markets may begin on a tepid note despite positive cues from Asian peers

Karan Dsij Article rating: 3.7

Indian markets are likely to be begin on a lacklustre note and may move ahead based on how the US-Saudi Arabia standoff pans out during the day. The SGX Nifty is trading with a marginal gain of 13 points at 10,532. Among Nifty 50 stocks, Hero Motocorp and Infosys are set to declare their results today.   

Overnight Digest: Stocks to look out for on October 16, 2018
Overnight Digest: Stocks to look out for on October 16, 2018

Overnight Digest: Stocks to look out for on October 16, 2018

Dnyanada Kulkarni Article rating: 3.9

The stocks most likely to witness significant movement on the bourses on October 16, 2018 are Pitti Engineering Solutions, Reliance Industrial Infrastructure Limited, Natco Pharma, Avenue Supermarts and Dr. Reddy’s Laboratories. 

Lupin receives tentative USFDA approval, stock tops Nifty pharma
Lupin receives tentative USFDA approval, stock tops Nifty pharma

Lupin receives tentative USFDA approval, stock tops Nifty pharma

Bhagyashree Vivarekar Article rating: 5.0

Lupin, the sixth largest pharma company by market capitalisation, received tentative US FDA approval for its generic Lurasidone Tablets of 20, 40, 60, 80 and 120 mg. Lupin which holds 8.8 per cent weightage in the Nifty pharma index was the top gainer in the index and surged 5 per cent on a closing basis. 

Mid-cap, small-cap outperforms
Mid-cap, small-cap outperforms

Mid-cap, small-cap outperforms

Gayathri Udyawar Article rating: 5.0

The broad market indices BSE Mid-cap and Small-cap index registered handsome gains. The BSE Mid-cap index gained 0.62 per cent, while small-cap index was up by 1.37 per cent on Monday.

Benchmark indices bewildered, CPI and WPI moderately higher
Benchmark indices bewildered, CPI and WPI moderately higher

Benchmark indices bewildered, CPI and WPI moderately higher

Bhagyashree Vivarekar Article rating: 5.0

Continuing with the optimism shown on Friday, the Indian stock markets opened Monday’s session on a positive note but witnessed range-bound volatility during the day. Bounce back in the Indian rupee by 50 paise and Brent oil by 40 paise brought in some pessimism in the markets. The country reported WPI and CPI inflation. 

Glenmark Pharma gets USFDA approval for skin cream
Glenmark Pharma gets USFDA approval for skin cream

Glenmark Pharma gets USFDA approval for skin cream

Shohini Nath Article rating: 5.0

Glenmark Pharmaceuticals has been given a nod from the USFDA for Hydrocortisone Valerate Cream. The shares of the company went up by over 2 per cent.

 

RSS
First28222823282428252827282928302831Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR